Polymorphism screening in the cardiac K+ channel gene KCNA5

Clinical Pharmacology and Therapeutics

Volumn 77, Issue 3, 2005, Pages 138-144

  Simard, Chantale ^a   Drolet, Benoit ^a   Yang, Ping ^a   Kim, Richard B ^a   Roden, Dan M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL; PROPAFENONE; QUINIDINE;

ALLELE; ANIMAL CELL; ARTICLE; CHANNEL GATING; CHO CELL; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC DIFFERENCE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC CODE; HEART ELECTROPHYSIOLOGY; HUMAN; LONG QT SYNDROME; NONHUMAN; POTASSIUM CHANNEL KCNA5 GENE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; ELECTROPHYSIOLOGY; GENE EXPRESSION; GENETIC SCREENING; HUMANS; ION CHANNEL GATING; KV1.5 POTASSIUM CHANNEL; MICE; PATCH-CLAMP TECHNIQUES; POLYMORPHISM, GENETIC; POTASSIUM CHANNELS, VOLTAGE-GATED; RATS;

EID: 13944273820     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2004.10.008     Document Type: Article

References (27)

1. H.L. McLeod, W.E. Evans Pharmacogenomics: unlocking the human genome for better drug therapy Annu Rev Pharmacol Toxicol 41 2001 101 121
2. K.M. Small, D.W. McGraw, S.B. Liggett Pharmacology and physiology of human adrenergic receptor polymorphisms Annu Rev Pharmacol Toxicol 43 2003 381 411
3. D.M. Roden, A.L. George Jr The genetic basis of variability in drug responses Nat Rev Drug Discov 1 2002 37 44
4. M.T. Keating, M.C. Sanguinetti Molecular and cellular mechanisms of cardiac arrhythmias Cell 104 2001 569 580
5. I. Splawski, K.W. Timothy, M. Tateyama, C.E. Clancy, A. Malhotra, A.H. Beggs Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia Science 297 2002 1333 1336
6. P.C. Viswanathan, D.W. Benson, J.R. Balser A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation J Clin Invest 111 2003 341 346
7. E. Pietila, H. Fodstad, E. Niskasaari, P.P.J. Laitinen, H. Swan, M. Savolainen Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women J Am Coll Cardiol 40 2002 511 514
8. C.R. Bezzina, A.O. Verkerk, A. Busjahn, A. Jeron, J. Erdmann, T.T. Koopmann A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization Cardiovasc Res 59 2003 27 36
9. K.J. Paavonen, H. Chapman, P.J. Laitinen, H. Fodstad, K. Piippo, H. Swan Functional characterization of the common amino acid 897 polymorphism of the cardiac potassium channel KCNH2 (HERG) Cardiovasc Res 59 2003 603 611
10. J. Wei, I.C. Yang, A.R. Tapper KCNE1 polymorphism confers risk of drug-induced long QT syndrome by altering kinetic properties of IKs potassium channel [abstract] Circulation 100 1999 I-145
11. L.P. Lai, M.J. Su, H.M. Yeh, J.L. Lin, F.T. Chiang, J.J. Hwang Association of the human minK gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation Am Heart J 144 2002 485 490
12. F. Sesti, G.W. Abbott, J. Wei, K.T. Murray, S. Saksena, P.J. Schwartz A common polymorphism associated with antibiotic-induced cardiac arrhythmia Proc Natl Acad Sci U S A 97 2000 10613 10618
13. S. Nattel New ideas about atrial fibrillation 50 years on Nature 415 2002 219 226
14. H. Iwasa, M. Kurabayashi, R. Nagai, Y. Nakamura, T. Tanaka Twenty single-nucleotide polymorphisms in four genes encoding cardiac ion channels J Hum Genet 47 2002 208 212
15. F.S. Collins, L.D. Brooks, A. Chakravarti A DNA polymorphism discovery resource for research on human genetic variation Genome Res 8 1998 1229 1231
16. T. Yang, D. Snyders, D.M. Roden Drug block of I(kr): model systems and relevance to human arrhythmias J Cardiovasc Pharmacol 38 2001 737 744
17. S.W. Yeola, T.C. Rich, V.N. Uebele, M.M. Tamkun, D.J. Snyders Molecular analysis of a binding site for quinidine in a human cardiac delayed rectifier K+ channel Role of S6 in antiarrhythmic drug binding Circ Res 78 1996 1105 1114
18. L. Franqueza, C. Valenzuela, E. Delpon, M. Longobardo, R. Caballero, J. Tamargo Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels Br J Pharmacol 125 1998 969 978
19. D.S. Ragsdale, J.C. McPhee, T. Scheuer, W.A. Catterall Molecular determinants of state-dependent block of Na+ channels by local anesthetics Science 265 1994 1724 1728
20. T. Weiser, Y. Qu, W.A. Catterall, T. Scheuer Differential interaction of R-mexiletine with the local anesthetic receptor site on brain and heart sodium channel α-subunits Mol Pharmacol 56 1999 1238 1244
21. A. Schuster, L. Lacinova, N. Klugbauer, H. Ito, L. Birnbaumer, F. Hofmann The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines EMBO J 15 1996 2365 2370
22. J.S. Mitcheson, J. Chen, M. Lin, C. Culberson, M.C. Sanguinetti A structural basis for drug-induced long QT syndrome Proc Natl Acad Sci U S A 97 2000 12329 12333
23. G. Seebohm, J. Chen, N. Strutz, C. Culberson, C. Lerche, M.C. Sanguinetti Molecular determinants of KCNQ1 channel block by a benzodiazepine Mol Pharmacol 64 2003 70 77
24. V.N. Uebele, S.W. Yeola, D.J. Snyders, M.M. Tamkun Deletion of highly conserved C-terminal sequences in the Kv1 K+ channel sub-family does not prevent expression of currents with wild-type characteristics FEBS Lett 340 1994 104 108
25. N. Blom, S. Gammeltoft, S. Brunak Sequence and structure-based prediction of eukaryotic protein phosphorylation sites J Mol Biol 294 1999 1351 1362
26. T. Yang, H. Kanki, D.M. Roden Phosphorylation of IKs channel complex inhibits drug block Novel mechanism underlying variable antiarrhythmic drug actions Circulation 108 2003 132 134
27. P. Dorian Antiarrhythmic drug therapy of atrial fibrillation: focus on new agents J Cardiovasc Pharmacol Ther 8 Suppl 1 2003 S27 S31